Skip to main content
. 2020 Feb 14;26(6):670–685. doi: 10.3748/wjg.v26.i6.670

Table 4.

Univariate analysis

Factors Recurrence group (n = 33) Non-recurrence group (n = 45) t /χ2 P value
Gender 2.792 0.095
Male (n = 44) 15 (45.45) 29 (64.44)
Female (n = 34) 18 (54.55) 16 (35.56)
Age (yr) 0.179 0.672
≥ 60 (n = 38) 17 (51.52) 21 (46.67)
< 60 (n = 40) 16 (48.48) 24 (53.33)
Smoking history 0.694 0.405
Yes (n=43) 20 (60.61) 23 (51.11)
No (n=35) 13 (39.39) 22 (48.89)
History of alcoholism 1.319 0.251
Yes (n=14) 4 (12.12) 10 (22.22)
No (n=64) 29 (87.88) 35 (77.78)
Lesion location 0.602 0.740
The upper thoracic area (n = 19) 7 (21.21) 12 (26.67)
The middle thoracic area (n = 34) 16 (48.49) 18 (40.00)
The lower thoracic area (n = 25) 10 (30.30) 15 (33.33)
Tumor size 7.648 0.006
≥ 3 cm (n = 45) 25 (75.76) 20 (44.44)
< 3 cm (n = 33) 8 (24.24) 25 (55.56)
Differentiation 7.093 0.008
Low differentiation (n = 25) 16 (48.48) 9 (20.00)
Moderate + high differentiation (n = 53) 17 (51.52) 36 (80.00)
TNM staging 6.825 0.009
Stage I (n = 27) 6 (18.18) 21 (46.67)
Stage II + III (n = 51) 27 (81.82) 24 (53.33)
Adjuvant therapy 0.946 0.331
Chemotherapy (n = 52) 24 (72.73) 28 (62.22)
Radiotherapy (n = 26) 9 (27.27) 17 (37.78)
Expression of miR-1304 8.877 0.003
High expression (n = 39) 23 (69.70) 16 (35.56)
Low expression (n = 39) 10 (30.30) 29 (64.44)